R&D Partner Content 4th LNP Immunogenicity & Toxicity Summit Assessing LNP Immunogenicity & Toxicity to Effectively Monitor Clinical Safety & Ensure Regulatory Compliance for Novel Therapeutics & Vaccines
R&D Partner Content Itching for derm progress? We’ve got the cure. Join 120+ peers at the 9th Dermatology Drug Development Summit
R&D Partner Content 2nd ADC Pharmacokinetics & Clinical Pharmacology Summit Bringing together leaders in PKPD, bioanalysis, pharmacometrics, and clinical pharmacology
R&D Partner Content 6th Gene Therapy for Ophthalmic Disorders Summit | Don’t Tur... Restoring Vision through Genetic Medicine
R&D Partner Content 7th Gene Therapy for CNS Summit | An Intimate Networking Spa... Unlocking Safe & Efficacious CNS Gene Therapy
R&D Partner Content 7th Gene Therapy Analytical Development Summit | Leading AD ... Advancing Analytics & QC from Pre-IND to BLA
News Ipsen' Bylvay fluffs its lines in biliary atresia trial Ipsen's IBAT inhibitor Bylvay has failed a trial in biliary atresia, a rare and serious liver disease that affects babies and has limited treatments.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.